Literature DB >> 18500497

Clinical features and associated syndromes of mal de debarquement.

Yoon-Hee Cha1, Jae Brodsky, Gail Ishiyama, Chiara Sabatti, Robert W Baloh.   

Abstract

OBJECTIVE: To investigate the clinical features and natural history of mal de debarquement (MdD).
DESIGN: Retrospective case review with follow-up questionnaire and telephone interviews.
SETTING: University Neurotology Clinic. PATIENTS: Patients seen between 1980 and 2006 who developed a persistent sensation of rocking or swaying for at least 3 days after exposure to passive motion. MAIN OUTCOME MEASURE: Clinical features,diagnostic testing, and questionnaire responses.
RESULTS: Of 64 patients(75% women) identified with MdD, 34 completed follow-up questionnaires and interviews in 2006. Most patients had normal neurological exams, ENGs and brain MRIs. The average age of the first MdD episode was 39+/-13 years. A total of 206 episodes were experienced by 64 patients. Of these, 104 episodes (51%) lasted>1 month; 18%, >1 year; 15%, >2 years; 12%, >4 years, and 11%, >5 years. Eighteen patients (28%) subsequently developed spontaneous episodes of MdD-like symptoms after the initial MdD episode.There was a much higher rate of migraine in patients who went onto develop spontaneous episodes(73%) than in those who did not(22%). Subsequent episodes were longer than earlier ones in most patients who had multiple episodes.Re-exposure to passive motion temporarily decreased symptoms in most patients (66%).Subjective intolerance to visual motion increased (10% to 66%)but self-motion sensitivity did not(37% to 50%) with onset of MdD.
CONCLUSION: The majority of MdD episodes lasting longer than 3 days resolve in less than one year but the probability of resolution declines each year. Many patients experience multiple MdD episodes. Some patients develop spontaneous episodes after the initial motion-triggered episode with migraine being a risk factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500497      PMCID: PMC2820362          DOI: 10.1007/s00415-008-0837-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Foot sole and ankle muscle inputs contribute jointly to human erect posture regulation.

Authors:  A Kavounoudias; R Roll; J P Roll
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  Survey of mal de debarquement.

Authors:  C R Gordon; O Spitzer; A Shupak; I Doweck
Journal:  BMJ       Date:  1992-02-29

4.  Mal de debarquement: pseudo-hallucinations from vestibular memory?

Authors:  Laura Moeller; Thomas Lempert
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

5.  Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man.

Authors:  T C Britton; B L Day; P Brown; J C Rothwell; P D Thompson; C D Marsden
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

6.  Compensation for labyrinthine defects examined by use of a tilting room.

Authors:  W Bles; J M Vianney de Jong; G de Wit
Journal:  Acta Otolaryngol       Date:  1983 May-Jun       Impact factor: 1.494

7.  The role of vection, eye movements and postural instability in the etiology of motion sickness.

Authors:  Moira B Flanagan; James G May; Thomas G Dobie
Journal:  J Vestib Res       Date:  2004       Impact factor: 2.435

8.  Persistent mal de debarquement syndrome: a motion-induced subjective disorder of balance.

Authors:  J J Brown; R W Baloh
Journal:  Am J Otolaryngol       Date:  1987 Jul-Aug       Impact factor: 1.808

9.  Role of somatosensory and vestibular cues in attenuating visually induced human postural sway.

Authors:  R J Peterka; M S Benolken
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

10.  Motion sickness adaptation: a neural mismatch model.

Authors:  J T Reason
Journal:  J R Soc Med       Date:  1978-11       Impact factor: 18.000

View more
  39 in total

1.  Exploring the pathophysiology of mal de debarquement.

Authors:  Brian C Clark; Adam Quick
Journal:  J Neurol       Date:  2010-12-19       Impact factor: 4.849

2.  Mal de debarquement syndrome: new insights.

Authors:  Yoon-Hee Cha
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

3.  Management of mal de debarquement syndrome as vestibular migraines.

Authors:  Yaser Ghavami; Yarah M Haidar; Kasra N Ziai; Omid Moshtaghi; Jay Bhatt; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope       Date:  2016-10-12       Impact factor: 3.325

4.  Rocking dizziness and headache: a two-way street.

Authors:  Yoon-Hee Cha; Yongyan Cui
Journal:  Cephalalgia       Date:  2013-05-14       Impact factor: 6.292

5.  Letter to the Editor: comment and erratum to "Mal de debarquement syndrome: a systematic review".

Authors:  Angelique Van Ombergen; Floris L Wuyts; Yoon-Hee Cha
Journal:  J Neurol       Date:  2016-04-11       Impact factor: 4.849

6.  Mal de débarquement syndrome: Review and proposed diagnostic criteria.

Authors:  Kamala C Saha; Terry D Fife
Journal:  Neurol Clin Pract       Date:  2015-06

7.  Double-Blind Sham-Controlled Crossover Trial of Repetitive Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome.

Authors:  Yoon-Hee Cha; Choi Deblieck; Allan D Wu
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

Review 8.  Mal de debarquement.

Authors:  Yoon-Hee Cha
Journal:  Semin Neurol       Date:  2009-10-15       Impact factor: 3.420

9.  Repetitive transcranial magnetic stimulation for mal de debarquement syndrome.

Authors:  Yoon-Hee Cha; Yongyan Cui; Robert W Baloh
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

10.  Adaptation of the angular vestibulo-ocular reflex to head movements in rotating frames of reference.

Authors:  Mingjia Dai; Theodore Raphan; Bernard Cohen
Journal:  Exp Brain Res       Date:  2009-05-21       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.